Enovis

Enovis EBITDA per Employee

The EBITDA per Employee of Enovis (ENOV) as of Oct 17, 2026 is -2,418.48 USD. In the previous year, EBITDA per Employee was -54,869.39 USD — a change of -95.59% (higher).

EBITDA per Employee

-2,418.48USD

YoY

-95.59%

Last updated:

EBITDA per Employee of Enovis is 2025 -2,418.48 USD. EBITDA per Employee of Enovis was 2024 -54,869.39 USD. It decreases by -95.59% higher compared to the previous year.

The Enovis EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
42,262.11 USD
Jan 1, 2019
39,190.59 USD
Jan 1, 2020
41,107.15 USD
Jan 1, 2021
6,952.83 USD
Jan 1, 2022
24,201.87 USD
Jan 1, 2023
29,010.25 USD
Jan 1, 2024
-54,869.39 USD
Jan 1, 2025
-2,418.48 USD
The Enovis EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-2,418.48USD-95.59%
-54,869.39USD-289.14%
29,010.25USD+19.87%
24,201.87USD+248.09%
6,952.83USD-83.09%
41,107.15USD+4.89%
39,190.59USD-7.27%
42,262.11USD+378.23%
8,837.22USD-76.66%
37,859.52USD+3.77%
36,483.59USD-30.50%
52,493.34USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enovis Stock analysis

What does Enovis do? Enovis Corp, listed on the stock market with ticker ENOV and ISIN US1940145022, is a health care company headquartered in Wilmington, United States. The company has 7,802 employees and went public on May 8, 2008. Enovis operates within the health care sector, focusing on medical technology and the development of clinically differentiated solutions. The company manufactures and distributes medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. It functions through two operational segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment offers products including rigid bracing, orthopedic soft goods, vascular systems, compression garments, and hot and cold therapy solutions, alongside recovery sciences products such as bone growth stimulators and electrical stimulators for clinical rehabilitation and sports medicine. The Reconstructive segment specializes in knee, hip, shoulder, elbow, foot, ankle, and finger implant products, as well as surgical productivity solutions. Additionally, Enovis provides Novastep, a minimally invasive surgery solution for foot and ankle procedures. The company's website is www.enovis.com. Enovis Corp is engaged in the production and distribution of medical devices aimed at improving patient outcomes through innovative technology and solutions in the health care industry. Enovis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enovis stock

EBITDA per Employee of Enovis is -2,418.48 USD in 2025.

EBITDA per Employee of Enovis changed from -54,869.39 USD to -2,418.48 USD, representing a -95.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Enovis since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Enovis historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Enovis

All Key Metrics — Enovis